Last edition
News about "Catherine Owen Adams"
EU Approves DAYBU (Trofinetide) for Rett Syndrome
The European Commission (EC) approves DAYBU (trofinetide) as the first and only treatment for Rett syndrome neurobehavioral symptoms across the European Union (EU) and EEA.
Catherine Owen Adams | 24/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members